 Bronchoalveolar Lavage Fluid
"Bronchoalveolar Lavage Fluid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung.
| Descriptor ID |
D001992
|
| MeSH Number(s) |
E05.927.100.500
|
| Concept/Terms |
Bronchoalveolar Lavage Fluid- Bronchoalveolar Lavage Fluid
- Bronchoalveolar Lavage Fluids
- Lavage Fluid, Bronchoalveolar
- Lavage Fluids, Bronchoalveolar
- Bronchial Alveolar Lavage Fluid
- Pulmonary Lavage Fluid
- Lavage Fluid, Pulmonary
- Lavage Fluids, Pulmonary
- Pulmonary Lavage Fluids
- Lavage Fluid, Bronchial
- Lavage Fluid, Lung
- Lung Lavage Fluid
- Lavage Fluids, Lung
- Lung Lavage Fluids
- Alveolar Lavage Fluid
- Alveolar Lavage Fluids
- Lavage Fluid, Alveolar
- Lavage Fluids, Alveolar
- Bronchial Lavage Fluid
- Bronchial Lavage Fluids
- Lavage Fluids, Bronchial
|
Below are MeSH descriptors whose meaning is more general than "Bronchoalveolar Lavage Fluid".
Below are MeSH descriptors whose meaning is more specific than "Bronchoalveolar Lavage Fluid".
This graph shows the total number of publications written about "Bronchoalveolar Lavage Fluid" by people in this website by year, and whether "Bronchoalveolar Lavage Fluid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 0 | 1 | 1 | | 1992 | 0 | 3 | 3 | | 1994 | 2 | 0 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 4 | 0 | 4 | | 1997 | 4 | 0 | 4 | | 1999 | 3 | 2 | 5 | | 2000 | 3 | 2 | 5 | | 2001 | 0 | 1 | 1 | | 2002 | 2 | 2 | 4 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 4 | 5 | | 2005 | 0 | 5 | 5 | | 2006 | 0 | 4 | 4 | | 2007 | 0 | 2 | 2 | | 2009 | 0 | 3 | 3 | | 2010 | 0 | 2 | 2 | | 2012 | 2 | 3 | 5 | | 2013 | 0 | 3 | 3 | | 2014 | 1 | 3 | 4 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchoalveolar Lavage Fluid" by people in Profiles.
-
Seidl E, Kiermeier H, Liebisch G, Ballmann M, Hesse S, Paul-Buck K, Ratjen F, Rietschel E, Griese M. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. J Cyst Fibros. 2019 11; 18(6):790-795.
-
Pilecki B, Wulf-Johansson H, Støttrup C, Jørgensen PT, Djiadeu P, Nexøe AB, Schlosser A, Hansen SWK, Madsen J, Clark HW, Nielsen CH, Vestbo J, Palaniyar N, Holmskov U, Sorensen GL. Surfactant Protein D Deficiency Aggravates Cigarette Smoke-Induced Lung Inflammation by Upregulation of Ceramide Synthesis. Front Immunol. 2018; 9:3013.
-
Yanik GA, Grupp SA, Pulsipher MA, Levine JE, Schultz KR, Wall DA, Langholz B, Dvorak CC, Alangaden K, Goyal RK, White ES, Collura JM, Skeens MA, Eid S, Pierce EM, Cooke KR. TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521). Biol Blood Marrow Transplant. 2015 Jan; 21(1):67-73.
-
Tiringer K, Treis A, Kanolzer S, Witt C, Ghanim B, Gruber S, Schmidthaler K, Renner S, Dehlink E, Nachbaur E, Frischer T, Klepetko W, Akdis CA, Szépfalusi Z, Eiwegger T. Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients. Eur Respir J. 2014 Sep; 44(3):802-5.
-
Côté O, Clark ME, Viel L, Labbé G, Seah SY, Khan MA, Douda DN, Palaniyar N, Bienzle D. Secretoglobin 1A1 and 1A1A differentially regulate neutrophil reactive oxygen species production, phagocytosis and extracellular trap formation. PLoS One. 2014; 9(4):e96217.
-
Luong ML, Chaparro C, Stephenson A, Rotstein C, Singer LG, Waters V, Azad S, Keshavjee S, Tullis E, Husain S. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis. Transplantation. 2014 Feb 15; 97(3):351-7.
-
Tibboel J, Reiss I, de Jongste JC, Post M. Ceramides: a potential therapeutic target in pulmonary emphysema. Respir Res. 2013 Oct 01; 14:96.
-
Tiringer K, Treis A, Fucik P, Gona M, Gruber S, Renner S, Dehlink E, Nachbaur E, Horak F, Jaksch P, Döring G, Crameri R, Jung A, Rochat MK, Hörmann M, Spittler A, Klepetko W, Akdis CA, Szépfalusi Z, Frischer T, Eiwegger T. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2013 Mar 15; 187(6):621-9.
-
Uematsu S, Engelberts D, Peltekova V, Otulakowski G, Post M, Kavanagh BP. Dissociation of inflammatory mediators and function: experimental lung injury in nonpulmonary sepsis. Crit Care Med. 2013 Jan; 41(1):151-8.
-
Griese M, Heinrich S, Ratjen F, Kabesch M, Paul K, Ballmann M, Rietschel E, Kappler M. Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome. PLoS One. 2012; 7(12):e51050.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|